DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

Referenz

Esposito S, Birlutiu V, Jarcuska P, Perino A, Man SC, Vladareanu R et al.
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered according to an alternative dosing schedule compared with the standard dosing schedule in healthy women aged 15 to 25 years: results from a randomized study.

Ped Inf Dis J 2011;
30: e49-e55

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: